Next Article in Journal
Design, Manufacturing, Characterization and Evaluation of Lipid Nanocapsules to Enhance the Biopharmaceutical Properties of Efavirenz
Next Article in Special Issue
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia
Previous Article in Journal
Synthesis and Evaluation of Small Molecule Drug Conjugates Harnessing Thioester-Linked Maytansinoids
Previous Article in Special Issue
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(7), 1317; https://doi.org/10.3390/pharmaceutics14071317
Action Date Notes Link
article pdf uploaded. 21 June 2022 15:14 CEST Version of Record https://www.mdpi.com/1999-4923/14/7/1317/pdf-vor
article supplementary file uploaded. 21 June 2022 15:14 CEST - https://www.mdpi.com/1999-4923/14/7/1317#supplementary
article xml file uploaded 1 July 2022 12:17 CEST Original file -
article xml uploaded. 1 July 2022 12:17 CEST Update https://www.mdpi.com/1999-4923/14/7/1317/xml
article pdf uploaded. 1 July 2022 12:17 CEST Updated version of record https://www.mdpi.com/1999-4923/14/7/1317/pdf
article html file updated 1 July 2022 12:18 CEST Original file -
article html file updated 4 July 2022 04:13 CEST Update -
article supplementary file uploaded. 4 July 2022 04:13 CEST - https://www.mdpi.com/1999-4923/14/7/1317#supplementary
article html file updated 12 August 2022 21:39 CEST Update https://www.mdpi.com/1999-4923/14/7/1317/html
Back to TopTop